Gene · 4986
Papers4,507
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 4,507
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lack of Association between (AAT)n Polymorphism of the CNR1 Gene Encoding the Cannabinoid Receptor (CB1) and Patient's Quality of Life. | Genes (Basel) | 2022 | 36360283 | PubTator, text mining | PubMed |
| Mind the Gap-Deciphering GPCR Pharmacology Using 3D Pharmacophores and Artificial Intelligence. | Pharmaceuticals (Basel) | 2022 | 36355476 | PubTator, text mining | PubMed |
| Targeting KNDy neurons to control GnRH pulses. | Curr Opin Pharmacol | 2022 | 36347163 | PubTator, text mining | PubMed |
| In vivo Characterization of the Opioid Receptor-Binding Profiles of Samidorphan and Naltrexone in Rats: Comparisons at Clinically Relevant Concentrations. | Neuropsychiatr Dis Treat | 2022 | 36345421 | PubTator, text mining | PubMed |
| Potential mechanism of the Shunaoxin pill for preventing cognitive impairment in type 2 diabetes mellitus. | Front Neurol | 2022 | 36341127 | PubTator, text mining | PubMed |
| Genetic architecture of Parkinson's disease subtypes - Review of the literature. | Front Aging Neurosci | 2022 | 36337703 | PubTator, text mining | PubMed |
| DNA methylome in pancreatic cancer identified novel promoter hyper-methylation in NPY and FAIM2 genes associated with poor prognosis in Indian patient cohort. | Cancer Cell Int | 2022 | 36329447 | PubTator, text mining | PubMed |
| Low-Dose Augmentation With Buprenorphine for Treatment-Resistant Depression: A Multisite Randomized Controlled Trial With Multimodal Assessment of Target Engagement. | Biol Psychiatry Glob Open Sci | 2022 | 36325158 | PubTator, text mining | PubMed |
| Looking Back, Looking Forward: Current Medications and Innovative Potential Medications to Treat Alcohol Use Disorder. | Alcohol Res | 2022 | 36320345 | PubTator, text mining | PubMed |
| Elevation of IgE in patients with psoriasis: Is it a paradoxical phenomenon? | Front Med (Lausanne) | 2022 | 36314037 | PubTator, text mining | PubMed |
| The apelin/APJ signaling system and cytoprotection: Role of its cross-talk with kappa opioid receptor. | Eur J Pharmacol | 2022 | 36306927 | PubTator, text mining | PubMed |
| Mapping neurotransmitter systems to the structural and functional organization of the human neocortex. | Nat Neurosci | 2022 | 36303070 | PubTator, text mining | PubMed |
| A Medical Resident with a History of Alcohol Abuse and Suicidal Ideation: A Challenge for Both Psychiatry and Occupational Medicine in the Context of the First Wave of the COVID-19 Pandemic. | Case Rep Psychiatry | 2022 | 36299477 | PubTator, text mining | PubMed |
| Evaluation of the Intracellular Signaling Activities of κ-Opioid Receptor Agonists, Nalfurafine Analogs; Focusing on the Selectivity of G-Protein- and β-Arrestin-Mediated Pathways. | Molecules | 2022 | 36296658 | PubTator, text mining | PubMed |
| Chronic Nodular Prurigo: An Update on the Pathogenesis and Treatment. | Int J Mol Sci | 2022 | 36293248 | PubTator, text mining | PubMed |
| Fine-Tuned Reactivity of N-Containing Naphthol Analogues. | Int J Mol Sci | 2022 | 36293186 | PubTator, text mining | PubMed |
| Seizing Control of Neuronal Activity: Chemogenetic Applications in Epilepsy. | Epilepsy Curr | 2022 | 36285203 | PubTator, text mining | PubMed |
| Current and emerging pharmacotherapies for opioid dependence treatments in adults: a comprehensive update. | Expert Opin Pharmacother | 2022 | 36278879 | PubTator, text mining | PubMed |
| The Amazonian kambô frog Phyllomedusa bicolor (Amphibia: Phyllomedusidae): Current knowledge on biology, phylogeography, toxinology, ethnopharmacology and medical aspects. | Front Pharmacol | 2022 | 36278168 | PubTator, text mining | PubMed |
| Sufentanil Combined with Nalbuphine via Patient-Controlled Intravenous Analgesia After Cesarean Section: A Retrospective Evaluation. | Drug Des Devel Ther | 2022 | 36277601 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4986/papers?page=37